Targeted Therapy
Targeted Therapy - Related Videos
02:57
Targeted Cancer Therapies
0 Views •
2021
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body. There are several types of targeted therapies against specific...
02:57
Targeted Cancer Therapies
0 Views •
2023
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body. There are several types of targeted therapies against specific...
08:03
Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
0 Views •
Cited by 7 •
2016
Photodynamic therapy (PDT) is an alternative choice for lung cancer treatment. To increase the therapeutic effect of PDT, lung cancer-targeted nanoparticles combined with chemotherapy were developed. Both in vitro and in vivo anticancer efficacies of PDT with prepared nanoparticles were evaluated.
12:03
Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy
0 Views •
Cited by 4 •
2016
Methods to evaluate the efficacy and toxicity of RNA molecules targeting post-integration steps of the HIV-1 replication cycle are described. These methods are useful for screening new molecules and optimizing the format of existing ones.
10:13
A Brain Tumor/Organotypic Slice Co-culture System for Studying Tumor Microenvironment and Targeted Drug Therapies
0 Views •
Cited by 29 •
2015
Many types of human brain tumors are localized to specific regions within the brain and are difficult to grow in culture. This protocol addresses the role of tumor microenvironment and investigates new drug treatments by analyzing fluorescent primary brain tumor cells growing in an organotypic mouse brain slice.
FAQs
Biomarker testing links a tumor’s molecular characteristics to a possible treatment strategy. Researchers examine features such as altered proteins, signaling activity, or other tumor-specific changes to determine whether a drug has a relevant target. This matching process supports more individualized treatment decisions and also helps investigators compare responses among cancers with different molecular profiles.
Kinases are enzymes that help transmit signals controlling cellular behavior, while growth-factor receptors receive external signals that can stimulate tumor growth. Drugs directed at these components can interrupt signaling pathways that support cancer progression. Studying these targets allows researchers to evaluate how blocking a specific molecular step affects tumor behavior and treatment response.
A cancer may progress after an initial response when resistance mechanisms weaken the effect of treatment. The overview identifies resistance as an important research focus because tumors can continue developing despite early benefit. By studying these mechanisms, investigators can examine why a therapy stops working, relate resistance to tumor characteristics, and improve understanding of later disease progression.
A study can begin by characterizing tumor molecules or biomarkers, followed by selecting a therapy directed at a relevant protein, enzyme, receptor, pathway, or cellular feature. Researchers then monitor treatment response and examine whether the tumor progresses despite initial benefit. This workflow connects molecular testing with therapeutic evaluation and investigation of resistance.
Investigators may use it when tumors differ in their molecular or biomarker profiles and need to be evaluated against treatments aimed at specific features. Comparing responses helps determine whether a particular characteristic is associated with treatment benefit. Such studies can clarify how molecular matching influences outcomes and support more precise approaches to cancer treatment research.
These studies can show whether disrupting a selected molecular feature limits tumor growth, whether treatment produces an initial benefit, and whether progression later occurs. They can also reveal relationships between biomarkers and response. Because the approach focuses on defined cellular targets, researchers can connect observed outcomes to signaling pathways, altered proteins, receptors, enzymes, or immune-marking processes.